or Try an Advanced Search...

    Technical Analysis for VOR - Vor Biopharma Inc.

    Grade Last Price % Change Price Change
    F 0.99 -1.07% -0.01
    VOR closed down 1.07 percent on Monday, July 1, 2024, on 1.22 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical VOR trend table...
    Date Alert Name Type % Chg
    MACD Bearish Signal Line Cross Bearish 0.00%
    New 52 Week Closing Low Bearish 0.00%
    Expansion Breakdown Bearish Swing Setup 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    New 52 Week Low Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Older End-of-Day Signals for VOR ...

       Recent Intraday Alerts

    Alert Time
    1.5x Volume Pace about 10 hours ago
    Down 5% about 10 hours ago
    Down 3% about 10 hours ago
    Fell Below Previous Day's Low about 10 hours ago
    Down 2 % about 10 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    VOR Chart by TradingView
    Basic chart:

    Profile

    Vor Biopharma, Inc. develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It offers VOR33, an eHSC product candidate that is in preclinical development to treat acute myeloid leukemia (AML). The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML cancer cells. Vor Biopharma, Inc. was incorporated in 2015 and is based in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Acute Myeloid Leukemia Tyrosine Kinase Receptors Therapies For Cancer Proteins Haematopoiesis Lintuzumab

    Is VOR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 10 Vor Biopharma GAAP EPS of $0.45
    May 9 Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update
    May 3 Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    May 2 Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
    Apr 4 Why You Shouldn't Bet Against Vor Biopharma (VOR) Stock
    Mar 29 Here's Why We're Watching Vor Biopharma's (NASDAQ:VOR) Cash Burn Situation
    Mar 20 Vor Biopharma GAAP EPS of -$0.39 beats by $0.11
    Mar 20 Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
    Mar 4 Vor Bio to Participate in Upcoming Investor Conferences
    Feb 17 Institutions own 36% of Vor Biopharma Inc. (NASDAQ:VOR) shares but private equity firms control 43% of the company
    See more VOR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.48
    52 Week Low 0.9136
    Average Volume 356,351
    200-Day Moving Average 1.97
    50-Day Moving Average 1.50
    20-Day Moving Average 1.21
    10-Day Moving Average 1.15
    Average True Range 0.10
    RSI (14) 24.81
    ADX 29.18
    +DI 12.13
    -DI 34.05
    Chandelier Exit (Long, 3 ATRs) 1.16
    Chandelier Exit (Short, 3 ATRs) 1.23
    Upper Bollinger Bands 1.41
    Lower Bollinger Band 1.01
    Percent B (%b) -0.06
    BandWidth 32.59
    MACD Line -0.13
    MACD Signal Line -0.12
    MACD Histogram -0.0038
    Fundamentals Value
    Market Cap 67.08 Million
    Num Shares 67.8 Million
    EPS -1.89
    Price-to-Earnings (P/E) Ratio -0.52
    Price-to-Sales 0.00
    Price-to-Book 0.89
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.25
    Resistance 3 (R3) 1.26 1.17 1.21
    Resistance 2 (R2) 1.17 1.11 1.17 1.20
    Resistance 1 (R1) 1.08 1.07 1.04 1.08 1.18
    Pivot Point 1.00 1.00 0.98 1.00 1.00
    Support 1 (S1) 0.91 0.93 0.86 0.90 0.80
    Support 2 (S2) 0.82 0.89 0.82 0.78
    Support 3 (S3) 0.73 0.82 0.77
    Support 4 (S4) 0.72